[1] |
ZHAO Jiao-jie,FU Lei,WANG Bin,ZHANG Lei,HU Ming-hao,LU Yu.
Establishment and application of pharmacodynamics and pharmacokinetics model in vitro
[J]. Chinese Journal of Antituberculosis, 2020, 42(4): 372-379.
|
[2] |
SONG Yan-hua,GAO Meng-qiu,LI Qi.
Research progress on the mechanism of drug resistance of Mycobacterium tuberculosis to ethionamide/pthionamide and ethionamide boosters
[J]. Chinese Journal of Antituberculosis, 2020, 42(2): 173-177.
|
[3] |
Maimaitiaili ·Aihemuti, HUANG Qiao-ling, Guerseman ·Abula, Renati ·Ailaiti.
Analysis of drug-resistance to rifampin and isoniazid in 1307 patients with pulmonary tuberculosis in Kashi, Xinjiang
[J]. Chinese Journal of Antituberculosis, 2020, 42(11): 1209-1213.
|
[4] |
LIU Er-yong, ZHOU Lin, XUE Xiao, LIU Chun-fa, BAI Li-qiong, LU Wei, ZHANG Tian-hua, CHENG Shi-ming.
Evaluation of treatment effect and safety of rifampicin capsule (Ⅱ) on pulmonary tuberculosis
[J]. Chinese Journal of Antituberculosis, 2020, 42(10): 1092-1099.
|
[5] |
ZHANG Man-e,HUANG Wen-bin,LU Zhi-hua,ZHANG Hong-bin.
Study on resistance to rifampicin and isoniazid in 411 cases of pulmonary tuberculosis in Longyan City, Fujian Province
[J]. Chinese Journal of Antituberculosis, 2020, 42(1): 54-59.
|
[6] |
Yuan LIU,Jun ZHOU,Xiao-li CUI,Jia-yuan LEI,Li-yun DANG.
Evaluation on the performance of gene chip and linear probe technique in detecting MTB drug resistance in sputum samples from smear-positive pulmonary tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2019, 41(7): 738-742.
|
[7] |
Bi-tong WU,Hao-bin KUANG,Zhi-hui LIU,Xing-shan CAI,Hong-juan QIN,Fan-rong MENG,Li-lan WU,Zhao-yuan LIN,De-hu PENG,Shou-yong TAN.
A comparative study of the efficacy of standard multidrug-resistant tuberculosis chemotherapy regimen for MDR-TB patients with pyrazinamide resistance or not
[J]. Chinese Journal of Antituberculosis, 2019, 41(4): 447-451.
|
[8] |
Xue-juan BAI,Yin-ping LIU,Jun-xian ZHANG,Jie WANG,Xue-qiong WU.
Direct detection of rifampicin and isoniazid resistance-associated genes in clinical specimens from the patients with tuberculosis using gene chip
[J]. Chinese Journal of Antituberculosis, 2019, 41(2): 138-144.
|
[9] |
Yuan LIU,Jun ZHOU,Xiao-li CUI,Jia-yuan LEI,Guo-lian ZHAO,Li-yun DANG.
The relationship between false-positive rifampicin resistant results of GeneXpert MTB/RIF and very low bacterial load in the clinical samples
[J]. Chinese Journal of Antituberculosis, 2019, 41(2): 176-180.
|
[10] |
JIANG Li-na,MU Cheng,SUN Rui,WANG Zhi-rui,DAI Wen-xi,WANG Chun-hua.
Detection value of the second-generation linear probe technique for drug resistance in Mycobacterium tuberculosis culture-positive isolates
[J]. Chinese Journal of Antituberculosis, 2019, 41(11): 1184-1190.
|
[11] |
Hui-na WU,Fu-sheng SUN,Qing-wen LIU,Zhong-lu RONG,Ji-dong ZHANG,Yang GAO,Yong-fu LI,Fei CHANG.
The value of fluorescent PCR probe melting curve analysis in detection of Mycobacterium tuberculosis complex for rifa-mpicin and isoniazid resistance
[J]. Chinese Journal of Antituberculosis, 2019, 41(1): 74-79.
|
[12] |
Yan LIU,Mulati Gulibike·,Abulitifu Maliyamu·,Xing YI,Jun-lian LI,Yong-huan SHI,Tian-jian LIU.
Results analysis on detection of drug resistance gene of Mycobacterium tuberculosis by using fluorescence PCR melting curve method
[J]. Chinese Journal of Antituberculosis, 2018, 40(9): 959-963.
|
[13] |
Shao-chen GUO,Hui ZHU,Chao GUO,Bin WANG,Zhong-quan LIU,Jian XU,Lei FU,Xiao-you CHEN,Yu LU.
Analysis of plasma concentrations of first-line anti-tuberculosis drugs in 909 tuberculosis patients
[J]. Chinese Journal of Antituberculosis, 2018, 40(7): 744-749.
|
[14] |
Xiao-qi DAI,Ren-zhong LI,Yun-zhou RUAN,Wei SU,Zhong-dong WANG,Li-xia. WANG.
Analysis on effects of isoniazid treatment in patients with rifampicin mono-/poly-drug-resistant tuberculosis
[J]. Chinese Journal of Antituberculosis, 2018, 40(6): 564-569.
|
[15] |
Qi-hui LIU,Feng SUN,Tao SUN,Xiao-fang JIA,Fei-fei SU,Ji-chan SHI,Li-jun ZHANG,Xian-gao JIANG,Wen-hong. ZHANG.
The relationship between plasma concentrations of the first-line anti-tuberculosis drugs and sputum negative conversion at early stage
[J]. Chinese Journal of Antituberculosis, 2018, 40(2): 157-160.
|